Login/Sign Up
Reliferon 3MIU Injection is used for the treatment of Follicular cancer, Hairy cell carcinoma, Malignant melanoma, AIDS-Related Kaposi's Sarcoma, Hodgkin's Lymphoma, Chronic hepatitis B, and Chronic hepatitis C. It contains Interferon alpha 2b as an active ingredient, which belongs to the class of immunomodulators. It works by inhibiting the abnormal growth of cancer cells. On the other hand, it also helps reduce the amount of hepatitis C virus (HCV) in the body.
₹617.025*
MRP ₹649.5
5% off
₹617.02*
MRP ₹649.5
5% CB
₹32.48 cashback(5%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Available Offers
Whats That
About Reliferon 3MIU Injection
Reliferon 3MIU Injection is an anti-cancer medicine used in the treatment of hairy cell leukaemia, follicular leukaemia, malignant leukaemia, AIDS-Related Kaposi’s Sarcoma, Hodgkin’s Lymphoma in combination with anthracycline-containing chemotherapy medicine, chronic hepatitis B and C. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.
Reliferon 3MIU Injection contains Interferon alpha 2b as an active ingredient, which belongs to the class of immunomodulators. It works by inhibiting the abnormal growth of cancer cells. It also helps reduce the amount of hepatitis C virus (HCV) in the body.
Reliferon 3MIU Injection may cause certain side effects such as flu-like symptoms, diarrhoea, fatigue, nausea, headache, dizziness, vomiting, tiredness, and injection site reactions. If the side effects persist or bother you, consult your doctor. Reliferon 3MIU Injection will be administered by a trained doctor. Hence, do not self-administer.
Avoid taking it and inform your doctor if you are allergic to Reliferon 3MIU Injection or its components. Inform your doctor if you have any cardiovascular conditions, liver/kidney disease, autoimmune hepatitis, a history of autoimmune disease, or HIV infection, as it can cause adverse effects. $ is not recommended for use in pregnancy as it is known to cause fetal harm. Breastfeeding should be avoided when on treatment with Reliferon 3MIU Injection .
Uses of Reliferon 3MIU Injection
Directions for Use
Medicinal Benefits
Reliferon 3MIU Injection contains Interferon alpha 2B, which is used for treating patients with different types of cancer. This medicine works by inhibiting the abnormal growth of cancer cells. It also helps reduce the amount of hepatitis C virus (HCV) in the body.
How Reliferon 3MIU Injection Works
Storage
Side Effects of Reliferon 3MIU Injection
What if I have taken an overdose of Reliferon 3MIU Injection
Drug Warnings
Reliferon 3MIU Injection should be avoided if you are allergic to it or any other components of this medicine. Before taking Reliferon 3MIU Injection , inform your doctor if you have any cardiovascular conditions, liver/kidney disease, autoimmune hepatitis, a history of autoimmune disease, or HIV infection, as it can cause adverse effects.. Reliferon 3MIU Injection may cause fetal harm. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Breastfeeding should be discontinued in nursing mothers during the treatment. Reliferon 3MIU Injection is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Product Substitutes
Alcohol
Caution
It is unknown whether Reliferon 3MIU Injection interacts with alcohol. Consult your doctor for more information.
Pregnancy
Unsafe
Reliferon 3MIU Injection is not recommended for use in pregnancy as it may cause fetal toxicity and harm your foetus. Hence, if you are pregnant or planning to be pregnant, inform your doctor before receiving Reliferon 3MIU Injection .
Breast Feeding
Unsafe
Reliferon 3MIU Injection should not be taken if you are breastfeeding, as it passes into breast milk and may harm your infant. Avoid nursing your child while on treatment with this medicine.
Driving
Caution
Reliferon 3MIU Injection will be administered to hospitalized patients. Driving is not recommended.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Reliferon 3MIU Injection . Reliferon 3MIU Injection may cause liver impairment. Hence, inform your doctor if you observe any symptoms such as jaundice, dark-coloured urine, or nausea. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Caution
Limited data are available on the effect of Reliferon 3MIU Injection in kidney-impaired patients. If you have a pre-existing or a history of kidney disease, inform your doctor.
Children
Unsafe
Reliferon 3MIU Injection is not recommended for use in children below 18 years as the safety and efficacy are not established.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information